ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 1000

$652K Total Retail Price of All Prescriptions

Rank: 168 out of 1000

727 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 727 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 727 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 13,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,136 921 1 3
HYDROCODONE-ACETAMINOPHEN 967 511 S3 2 1
LISINOPRIL 837 632 3 5
AMLODIPINE BESYLATE 822 683 4 6
LEVOTHYROXINE SODIUM 763 597 5 4
OMEPRAZOLE 761 549 6 2
CARVEDILOL 565 471 7 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 512 349 8 20
METFORMIN HCL 485 342 9 8
HYDROCHLOROTHIAZIDE 368 290 10 9
FUROSEMIDE 357 308 11 7
RANITIDINE HCL 342 268 12 37
LOVASTATIN 298 228 13 41
ZOLPIDEM TARTRATE 280 183 14 16
POTASSIUM CHLORIDE 274 220 15 10
GABAPENTIN 274 172 15 11
MELOXICAM 271 195 17 14
LOSARTAN POTASSIUM 266 246 18 25
METOPROLOL TARTRATE 259 185 19 19
CITALOPRAM HBR 248 182 20 17
WARFARIN SODIUM 226 168 21 22
TRAMADOL HCL 207 162 22 13
GLIMEPIRIDE 196 150 23 34
ENALAPRIL MALEATE 194 171 24 58
CRESTOR 186 135 25 30
LOSARTAN-HYDROCHLOROTHIAZIDE 164 163 26 38
METOPROLOL SUCCINATE 159 103 27 21
ADVAIR DISKUS 153 118 28 65
NEXIUM 152 97 29 23
FLUTICASONE PROPIONATE 140 105 30 40
ACETAMINOPHEN-CODEINE 140 97 S3 30 127
VENTOLIN HFA 138 91 32 83
ATORVASTATIN CALCIUM 133 117 33 18
CLOPIDOGREL 133 84 33 35
DONEPEZIL HCL 132 127 35 32
METFORMIN HCL ER 129 87 36 44
PRAVASTATIN SODIUM 124 90 37 12
SERTRALINE HCL 117 77 38 26
ALLOPURINOL 115 81 39 31
TAMSULOSIN HCL 107 72 40 33
CLONIDINE HCL 103 55 41 27
PREDNISONE 97 57 42 42
CYCLOBENZAPRINE HCL 93 21 R 43 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 89 73 44 101
PANTOPRAZOLE SODIUM 88 40 45 28
DIGOXIN 88 74 45 52
FLUOXETINE HCL 87 62 47 51
MIRTAZAPINE 84 71 48 56
VERAPAMIL ER 83 80 49 86
ISOSORBIDE MONONITRATE ER 82 75 50 71
AMIODARONE HCL 81 67 51 178
DIOVAN HCT 80 61 52 96
FENTANYL 79 0 S2 53 100
ATENOLOL 79 68 53 24
SPIRONOLACTONE 79 63 53 78
TORSEMIDE 78 69 56 137
HYDRALAZINE HCL 77 68 57 74
AMITRIPTYLINE HCL 77 59 R 57 45
JANUVIA 74 51 59 85
PLAVIX 72 56 60 49
PROAIR HFA 72 24 60 50
LANTUS 71 42 62 68
PAROXETINE HCL 70 40 63 63
LANTUS SOLOSTAR 63 29 64 120
FAMOTIDINE 62 40 65 88
LIPITOR 62 57 65 170
HUMULIN 70-30 61 35 67 131
AMLODIPINE BESYLATE-BENAZEPRIL 57 30 68 59
CIPROFLOXACIN HCL 56 49 69 46
ESCITALOPRAM OXALATE 55 40 70 60
INSULIN SYRINGE 55 38 70 93
SYNTHROID 55 42 70 91
TRAZODONE HCL 53 16 73 29
NAMENDA 52 52 74 43
JANUMET 51 35 75 195
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.